Detalles de la búsqueda
1.
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development.
Mol Pain
; 122016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27145802
2.
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
J Cancer Res Clin Oncol
; 147(1): 205-212, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683487
3.
Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy.
J Cancer Res Clin Oncol
; 145(3): 561-571, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30519736
4.
Characterization of small fiber pathology in a mouse model of Fabry disease.
Elife
; 72018 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328411
Resultados
1 -
4
de 4
1
Próxima >
>>